Functional Characterization of the Human Factor VII 5′-Flanking Region (*)
暂无分享,去创建一个
G C Overton | G. Overton | K. High | E. Pollak | K A High | E S Pollak | H L Hung | W Godin | H. Hung | Willis Godin
[1] Gene regulation by steroid hormones , 1989, Cell.
[2] H. Schulte,et al. Epidemiological Study on Factor VII, Factor VIII and Fibrinogen in an Industrial Population: I. Baseline Data on the Relation to Age, Gender, Body-Weight, Smoking, Alcohol, Pill-Using, and Menopause , 1985, Thrombosis and Haemostasis.
[3] D. Moore,et al. Human growth hormone as a reporter gene in regulation studies employing transient gene expression , 1986, Molecular and cellular biology.
[4] J. Suttie,et al. Vitamin K-dependent carboxylase. Development of a peptide substrate. , 1976, The Journal of biological chemistry.
[5] T. Meade,et al. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[6] K. Kario,et al. Fluorogenic assay of activated factor VII. Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[7] J. Darnell,et al. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. , 1990, Genes & development.
[8] R. Miller,et al. Correlation of factor VII activity and antigen with cholesterol and triglycerides in healthy young adults. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[9] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[10] Robert Tjian,et al. Mechanism of transcriptional activation by Sp1: Evidence for coactivators , 1990, Cell.
[11] R. Saiki,et al. A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. , 1988, Nucleic acids research.
[12] J. Cooper,et al. Dietary fat induces changes in factor VII coagulant activity through effects on plasma free stearic acid concentration. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[13] K. High,et al. Characterization of the human blood coagulation factor X promoter. , 1992, The Journal of biological chemistry.
[14] R. Marlar,et al. Biosynthesis and secretion of factor VII, protein C, protein S, and the Protein C inhibitor from a human hepatoma cell line. , 1986 .
[15] Pamela F. Jones,et al. The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases , 1995, Cell.
[16] P. Sharp,et al. A single polypeptide possesses the binding and transcription activities of the adenovirus major late transcription factor , 1986, Molecular and Cellular Biology.
[17] P. Reitsma,et al. Disruption of a binding site for hepatocyte nuclear factor 4 results in hemophilia B Leyden. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[18] D. Melton,et al. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. , 1984, Nucleic acids research.
[19] S. Nordeen,et al. Luciferase reporter gene vectors for analysis of promoters and enhancers. , 1988, BioTechniques.
[20] F. Grant,et al. Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[21] K. Kurachi,et al. Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). , 1985, Biochemistry.
[22] L. Guize,et al. Factor VII activation and menopausal status. , 1990, Thrombosis research.
[23] R. Roeder,et al. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.
[24] A. Folsom,et al. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. , 1991, Atherosclerosis.
[25] P. Bucher. Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. , 1990, Journal of molecular biology.
[26] G. Nelsestuen. Role of gamma-carboxyglutamic acid. An unusual protein transition required for the calcium-dependent binding of prothrombin to phospholipid. , 1976, The Journal of biological chemistry.
[27] L. Kedes,et al. Identification of multiple proteins that interact with functional regions of the human cardiac alpha-actin promoter , 1989, Molecular and cellular biology.
[28] C. Jamison,et al. Prenatal and postnatal expression of mRNA coding for rat prothrombin. , 1991, Biochimica et biophysica acta.
[29] E. Davie,et al. Liver-specific expression of the gene coding for human factor X, a blood coagulation factor. , 1992, Journal of Biological Chemistry.
[30] W. Gilbert,et al. Sequencing end-labeled DNA with base-specific chemical cleavages. , 1980, Methods in enzymology.
[31] B. Furie,et al. The molecular basis of blood coagulation , 1988, Cell.
[32] J. Bonnar. Coagulation effects of oral contraception. , 1987, American journal of obstetrics and gynecology.
[33] R. Cortese,et al. Two distinct factors interact with the promoter regions of several liver‐specific genes. , 1988, The EMBO journal.
[34] D. Fair. Quantitation of factor VII in the plasma of normal and warfarin-treated individuals by radioimmunoassay. , 1983 .
[35] J. Francis. Molecular Basis of Thrombosis and Hemostasis , 1996 .
[36] U. Schibler,et al. Tissue-specific in vitro transcription from the mouse albumin promoter , 1986, Cell.
[37] H. Okayama,et al. High-efficiency transformation of mammalian cells by plasmid DNA. , 1987, Molecular and cellular biology.
[38] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[39] J. Y. Chen,et al. Multiple parameters control the selectivity of nuclear receptors for their response elements. Selectivity and promiscuity in response element recognition by retinoic acid receptors and retinoid X receptors. , 1993, The Journal of biological chemistry.
[40] S. Thompson,et al. HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY , 1986, The Lancet.
[41] C. Jiang,et al. Start site selection by Sp1 in the TATA-less human Ha-ras promoter. , 1994, The Journal of biological chemistry.
[42] C C Howe,et al. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. , 1980, Science.
[43] Oxon Dm. Obituary. Rupert Samuel Bruce Pearson. , 1974 .
[44] D. Baltimore,et al. The “initiator” as a transcription control element , 1989, Cell.
[45] B. Osterud,et al. Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusion. , 1979, Blood.
[46] M. Adesnik,et al. Construction of mutant and chimeric genes using the polymerase chain reaction. , 1989, Nucleic acids research.
[47] S. Smale,et al. DNA sequence requirements for transcriptional initiator activity in mammalian cells. , 1994, Molecular and cellular biology.
[48] H. Roberts,et al. New perspectives on the coagulation cascade. , 1992, Hospital practice.
[49] J. Azizkhan,et al. Transcription from TATA-less promoters: dihydrofolate reductase as a model. , 1993, Critical reviews in eukaryotic gene expression.
[50] K. High,et al. Molecular Basis of Thrombosis and Hemostasis , 1995 .
[51] C. Bonithon-Kopp,et al. Relationship between sex hormones and haemostatic factors in healthy middle-aged men. , 1988, Atherosclerosis.
[52] F. Sanger,et al. DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[53] Ueli Schibler,et al. The interplay of DNA-binding proteins on the promoter of the mouse albumin gene , 1987, Cell.